KEAP1 and cancer: Suppression of the expression level of Nrf2 via applying a CRISPR/Cas9 genome editing system illustrated that ERBB3 and IGF1R signaling pathway accompanied by thioredoxin and peroxiredoxin proteins play an effective role in KEAP1-mutant cancer cells.